AVAI BIO, INC. (AVAI) Operating cash flow 2019–2026
AVAI BIO, INC. (AVAI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.0MFY2026 · since FY2019: -$84,165 → -$1.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$1.0M | +13.0% |
| FY2025 | -$1.2M | +12.2% |
| FY2024 | -$1.3M | -2328.2% |
| FY2023 | -$54,457 | -110.2% |
| FY2022 | $535,008 | +2217.1% |
| FY2021 | $23,090 | -82.3% |
| FY2020 | $130,718 | +255.3% |
| FY2019 | -$84,165 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AVAI financial trends
AVAI RevenueAVAI Net incomeAVAI Net marginAVAI Gross profitAVAI Gross marginAVAI Operating incomeAVAI Operating marginAVAI Free cash flowAVAI Capital expendituresAVAI Return on equityAVAI Stock buybacksAVAI Dividends paidAVAI Total assetsAVAI Total liabilitiesAVAI Shareholders’ equityAVAI overview →